OncoGenex Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- OncoGenex Pharmaceuticals's estimated annual revenue is currently $6M per year.
- OncoGenex Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- OncoGenex Pharmaceuticals has 39 Employees.
- OncoGenex Pharmaceuticals grew their employee count by -13% last year.
OncoGenex Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | VP Clinical Operations | Reveal Email/Phone |
4 | VP, Head Medical Affairs | Reveal Email/Phone |
5 | VP, CMC | Reveal Email/Phone |
6 | VP, Process Control and QA | Reveal Email/Phone |
7 | SVP, CMC and Regulatory CMC | Reveal Email/Phone |
8 | VP, Clinical Research | Reveal Email/Phone |
9 | EVP, Commercial | Reveal Email/Phone |
10 | Senior Director, Biometrics | Reveal Email/Phone |
OncoGenex Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $3.3M | 43 | 10% | $101M | N/A |
#4 | $5.7M | 37 | 12% | N/A | N/A |
#5 | $7M | 45 | 41% | N/A | N/A |
#6 | $1.7M | 22 | -8% | N/A | N/A |
#7 | $3.9M | 50 | 4% | $10.1M | N/A |
#8 | $1.9M | 12 | -73% | N/A | N/A |
#9 | $29.3M | 151 | -17% | $148M | N/A |
#10 | $2M | 13 | 86% | N/A | N/A |
What Is OncoGenex Pharmaceuticals?
Achieve Life Sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.
keywords:N/AN/A
Total Funding
39
Number of Employees
$6M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OncoGenex Pharmaceuticals News
2022-04-06 - Targeted Cancer Therapies Market 2022 Size, Share, Challenges, and Future
Business Outlook to 2028 | Abbott,
... GlaxoSmithKline plc, AstraZeneca PLC, OncoGenex Pharmaceuticals Inc., Pfizer, Inc., AVEO Pharmaceuticals Inc., and CYTOKINETICS INC.
2022-03-30 - Global Pharma, Biotech and Diagnostics Option and ...
Global Pharma, Biotech and Diagnostics Option and Evaluation Deals Report/Directory 2021: ... Case study 7: Teva - OncoGenex Pharmaceuticals
2022-03-22 - Targeted Cancer Therapies Market Expected to Expand at a ...
Abbott Laboratories, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, AstraZeneca PLC, OncoGenex Pharmaceuticals Inc., Pfizer,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8M | 39 | -36% | $197.5M |
#2 | $8.4M | 39 | 3% | N/A |
#3 | $7.1M | 39 | 18% | N/A |
#4 | $8.4M | 39 | 5% | N/A |
#5 | $7.5M | 39 | 5% | N/A |